The HDAC inhibitor SAHA can induce the conversion of T cells into functional Tregs and alleviate pulmonary hypertension, confirming the central role of metabolic-epigenetic crosstalk in regulating T cell function (Chen et al., 2023). Here, HDAC9 is linked to pulmonary arterial hypertension.